BOSTON, Nov. 9, 2011 /PRNewswire via COMTEX/ -- Arrangement aims to
accelerate development of new therapies through unique exchange of expertise in
basic science and preclinical drug development

Children's Hospital Boston and Pfizer Inc. /quotes/zigman/238207/quotes/nls/pfe PFE
-1.86% have
launched a new collaborative program aimed at identifying potential drug
therapies for Duchenne muscular dystrophy (DMD). At the heart of the one-year
collaborative research agreement is a novel exchange of expertise that brings
the respective strengths of academia and industry together in a framework that
could hold promise for benefitting DMD patients in the future.

http://www.marketwatch.com/story/childrens-hospital-boston-and-pfiz...